The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,812.50
Ask: 1,813.00
Change: 2.50 (0.14%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,820.00
Low: 1,803.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight

Thu, 07th Oct 2021 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

CITIGROUP RAISES LEGAL & GENERAL PRICE TARGET TO 336 (301) PENCE - 'BUY'

----------

MORGAN STANLEY CUTS GLAXOSMITHKLINE PRICE TARGET TO 1,555 PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS SCHRODERS TARGET TO 3,700 (3,890) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS HARGREAVES LANDSDOWN TARGET TO 1,381 PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS ABRDN PRICE TARGET TO 289 (305) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES PRUDENTIAL PRICE TARGET TO 1,764 (1,706) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES RENTOKIL INITIAL TARGET TO 645 (620) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES EXPERIAN PRICE TARGET TO 3,500 (3,320) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES ANGLO AMERICAN PRICE TARGET TO 4,100 (3,900) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS ANGLO AMERICAN PRICE TARGET TO 3,700 (4,300) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS RIO TINTO PRICE TARGET TO 5,400 (6,910) PENCE - 'NEUTRAL'

----------

BERENBERG CUTS RIO TINTO PRICE TARGET TO 5,400 (6,900) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES ANTOFAGASTA PRICE TARGET TO 1,750 (1,700) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES GLENCORE PRICE TARGET TO 470 (430) PENCE - 'BUY'

----------

BERENBERG CUTS BHP GROUP PRICE TARGET TO 2,200 (2,300) PENCE - 'HOLD'

----------

JEFFERIES CUTS POLYMETAL PRICE TARGET TO 1,725 (1,900) PENCE - 'BUY'

----------

BERENBERG CUTS POLYMETAL PRICE TARGET TO 2,200 (2,300) PENCE - 'BUY'

----------

JEFFERIES CUTS FRESNILLO PRICE TARGET TO 1,280 (1,300) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES RELX PRICE TARGET TO 2,500 (2,430) PENCE - 'OUTPERFORM'

----------

UBS RAISES RELX PRICE TARGET TO 2,135 (2,040) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES TESCO PRICE TARGET TO 330 (300) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES TESCO PRICE TARGET TO 320 (310) PENCE - 'BUY'

----------

BARCLAYS RAISES TESCO PRICE TARGET TO 325 (310) PENCE - 'OVERWEIGHT'

----------

BERNSTEIN RAISES TESCO PRICE TARGET TO 330 (280) PENCE - 'OUTPERFORM'

----------

RBC CUTS BURBERRY PRICE TARGET TO 1,950 (2,160) PENCE - 'SECTOR PERFORM'

----------

FTSE 250

----------

MORGAN STANLEY RAISES CENTRICA TO 'OVERWEIGHT' (EQUAL WEIGHT) - TARGET 75 (58) PENCE

----------

MORGAN STANLEY CUTS MAN GROUP PRICE TARGET TO 253 (255) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS ASHMORE GROUP TARGET TO 376 (412) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 340 (360) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS HOMESERVE TARGET TO 1,020 (1,110) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK INITIATES MARSHALLS WITH 'BUY' - TARGET 885 PENCE

----------

BERENBERG RAISES HOCHSCHILD MINING TO 'BUY' ('HOLD') - TARGET 200 PENCE

----------

BERENBERG CUTS CENTAMIN PRICE TARGET TO 137 (138) PENCE - 'BUY'

----------

JEFFERIES CUTS CENTAMIN PRICE TARGET TO 170 (175) PENCE - 'BUY'

----------

RBC RAISES PAGEGROUP PRICE TARGET TO 760 (700) PENCE - 'OUTPERFORM'

----------

RBC CUTS TRITAX BIG BOX PRICE TARGET TO 260 (265) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES BRITVIC PRICE TARGET TO 1050 (900) PENCE - 'BUY'

----------

JEFFERIES RAISES TRAVIS PERKINS PRICE TARGET TO 2,220 (2,168) PENCE - 'BUY'

----------

JEFFERIES RAISES OXFORD INSTRUMENTS PRICE TARGET TO 2,445 (2,415) PENCE - 'HOLD'

----------

DZ BANK CUTS FAIR VALUE FOR TUI TO 2.00 (2.60) EUR - 'SELL'

----------

MORGAN STANLEY CUTS TUI PRICE TARGET TO 140 (160) PENCE - 'UNDERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES GEM DIAMONDS TO 'BUY' ('HOLD') - TARGET 80 (70) PENCE

----------

BERENBERG RAISES IMPAX GROUP PRICE TARGET TO 1,400 (1,360) PENCE - 'BUY'

----------

BERENBERG RAISES PENDRAGON PRICE TARGET TO 28 (27) PENCE - 'BUY'

----------

RBC RAISES CVS GROUP PRICE TARGET TO 3,100 (2,750) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES KENMARE RESOURCES PRICE TARGET TO 580 (530) PENCE - 'BUY'

----------

BERENBERG CUTS GRIFFIN PRICE TARGET TO 175 (200) PENCE - 'BUY'

----------

BERENBERG CUTS GREATLAND GOLD PRICE TARGET TO 26 (29) PENCE - 'BUY'

----------

BERENBERG RAISES CENTRAL ASIA METALS PRICE TARGET TO 320 (300) PENCE - 'BUY'

----------

BERENBERG RAISES NICHOLS PRICE TARGET TO 1,350 (1,200) PENCE - 'HOLD'

----------

BERENBERG RAISES FEVERTREE DRINKS PRICE TARGET TO 2,700 (2,500) PENCE - 'BUY'

----------

BERENBERG RAISES AG BARR PRICE TARGET TO 570 (450) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES SUPERMARKET INCOME REIT PRICE TARGET TO 136 (134) PENCE - 'BUY'

----------

JPMORGAN RAISES PETROFAC PRICE TARGET TO 170 (120) PENCE - 'NEUTRAL'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.